Bicara Therapeutics (BCAX) Tax Provisions (2023 - 2026)
Bicara Therapeutics (BCAX) reported Tax Provisions of $52000.0 for Q1 2026, down 27.78% on a YoY basis from $72000.0 in Q1 2025, and down 1.89% quarter-over-quarter from $53000.0 in Q4 2025.
Bicara Therapeutics (BCAX) Tax Provisions (2023 - 2026) Analysis & Trends
Bicara Therapeutics has reported Tax Provisions for 4 years, with the latest figure at $52000.0 in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 27.78% year-over-year to $52000.0; the trailing twelve-month figure through Mar 2026 stood at $197000.0 (down 23.64% YoY), and the FY2025 full-year result was $217000.0, up 16.04% from the prior year.
- Tax Provisions for Q1 2026 stood at $52000.0, down from $53000.0 in the prior quarter.
- The five-year high for Tax Provisions was $186000.0 in Q4 2024, with the low at $1000.0 in Q1 2024.
- Historically, Tax Provisions has averaged $57625.0 across 4 years, with a median of $52000.0 in 2025.
- The largest YoY upside for Tax Provisions was 7100.0% in 2025 against a maximum downside of 71.51% in 2025.
- Bicara Therapeutics' Tax Provisions stood at $5000.0 in 2023, then jumped by 3620.0% to $186000.0 in 2024, then tumbled by 71.51% to $53000.0 in 2025, then slipped by 1.89% to $52000.0 in 2026.
- The last three Tax Provisions figures came in at $52000.0 (Q1 2026), $53000.0 (Q4 2025), and $40000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Bicara Therapeutics | 1.41 Bn | 1.41 Bn | - | 52,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52,000.00 |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 186,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 5,000.00 |